BINV — BioInvent International AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK1.49bn
- SEK909.54m
- SEK226.50m
Annual cashflow statement for BioInvent International AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -278 | -50.9 | -370 | -471 | -352 |
| Depreciation | |||||
| Non-Cash Items | 1.14 | 1.79 | 2.95 | 5.46 | 4.72 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 16.8 | -5.94 | 11.9 | 65.7 | 77.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -246 | -40.3 | -338 | -381 | -250 |
| Capital Expenditures | -13.3 | -12.4 | -13.3 | -10 | -7.26 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -454 | -616 | 73 | 574 | 187 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -468 | -629 | 59.7 | 564 | 180 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 895 | 273 | 23.1 | -8.46 | -8.98 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 181 | -396 | -255 | 175 | -78.7 |